Home Diagnostics is Named One of Forbes Magazine's "200 Best Small Companies"

Business Wire, Dec 16, 2008

FORT LAUDERDALE, Fla. -- Home Diagnostics, Inc. (Nasdaq:HDIX), a leading manufacturer and marketer of diabetes testing supplies, today announced that it was named one of Forbes magazine's "200 Best Small Companies" in the October 27 issue of the publication.

Home Diagnostics is one of 37 companies appearing on the Forbes list for the first time this year. In order to qualify a company must have had sales between $5 million and $750 million and a stock price of $5 as of September 29, 2008. Rankings were based on return on equity, sales growth and profit growth over the past 12 months as well as over five years. Forbes also compared each company's stock performance with that of its industry peers.

"The Forbes list of the 200 Best Small Companies seeks to identify the strongest public companies with sales under $750 million," said Kurt Badenhausen associate editor at Forbes. "These firms all have reasonable debt burdens and have had solid sales and earnings growth over the past five years."

"Being recognized by Forbes as one of the nation's best small companies is a testament to the success of Home Diagnostics' growth strategy," J. Richard Damron, Jr., president and CEO of Home Diagnostics. "National pharmacy chains, distributors and mail service providers trust our blood glucose monitoring systems to represent their own brands because we offer high-performance products at a significant cost savings to their diabetic customers. Our ability to capitalize on our unique distribution model and gain market share with competitive price points positions Home Diagnostics as a strong player in a growing $7 billion diabetes testing supplies market."

The company recently launched the world's smallest, no-coding blood glucose monitor, TRUE2go[TM]. Small enough to twist and attach to the top of a vial of test strips, TRUE2go offers patients the convenience of anywhere, on-the-go testing to help them better manage their condition. TRUEresult[TM] is the company's latest advanced performance, no-coding meter for at-home testing. Both new meters work with the company's new blood glucose test strips, TRUEtest, which feature the company's patent-pending, state-of-the-art GoldSensor[TM] laser accuracy technology and the TRUEfill[TM] beveled tip design which allow for highly accurate test results.

About Home Diagnostics, Inc.

Based in Fort Lauderdale, Florida, Home Diagnostics, Inc. (NASDAQ: HDIX) is a leading developer, manufacturer and marketer of diabetes management solutions. Home Diagnostics, Inc. offers a portfolio of high-quality blood glucose monitoring systems that spans the spectrum of features and benefits to help every person with diabetes better monitor and manage their disease. The Home Diagnostics, Inc. product line includes TRUE2go[TM], TRUEresult[TM], TRUEtrack[R], Sidekick[R], TRUEread[TM] and Prestige Smart System[R] blood glucose monitoring systems. The products are available in more than 45,000 pharmacies throughout the U.S. Home Diagnostics is the exclusive co-brand supplier of blood glucose monitoring supplies for leading pharmacies including CVS, Rite Aid and Walgreens as well as national distributors such as AmerisourceBergen, Cardinal Health and McKesson. Home Diagnostics, Inc. was named one of Forbes magazine's "200 Best Small Companies" in 2008. For more information please visit www.homediagnostics.com.

TRUE2go, TRUEresult, TRUEtest, TRUEtrack, Sidekick, TRUEread and Prestige Smart System are trademarks of Home Diagnostics, Inc. All other trademarks are property of their respective owners.

[HDIX-F]